Learn more Allow cookies Dismiss Cookie Preferences Investors & Media Careers Contact Us Home About Us Our Focus Our Pipeline Our Medicine For Patients/Healthcare Providers Changing the course of autoimmune disease Inspired by patients. Driven to make an impact. Latest News November 10, 2021 • 4:05pm EST Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference read press release view all news ••• © 2021 Aurinia Pharmaceuticals Inc. All Rights Reserved. Privacy Statement Terms of Use Disclaimer Aurinia Compliance Program Sitemap Update Consent

Investors & Media Careers Contact Us Home About Us Our Focus Our Pipeline Our Medicine For Patients/Healthcare Providers INVESTORS & MEDIA Overview News / Events Company Info Financial Info Stock Data SEC Filings Governance and Documents Investor Tools Investor Relations Latest News Nov 10, 2021 Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference Latest Financial Results Q3 2021 QUARTER ENDED SEP 30, 2021 PDF HTML Release Audio Earnings Webcast PDF HTML 10-Q Filing ZIP XLS HTML XBRL Stock Information Aurinia Pharmaceuticals Inc. NOV 24, 2021 • 4:00 PM EST Nasdaq: AUPH SYMBOL $19.71 PRICE 0.35 (1.81%) CHANGE 2.99m VOLUME 19.05 - 20.27 DAY RANGE 9.72 - 33.97 52 WK RANGE Company Overview Aurinia Pharmaceuticals is a late-stage clinical biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. Aurinia is actively exploring opportunities to fully realize the untapped potential of novel therapies and create meaningful impact to meet patient needs. The Company’s head office is in Victoria, British Columbia and its U.S. commercial hub is in Rockville, Maryland. The Company focuses its development efforts globally. VIEW MANAGEMENT TEAM VIEW BOARD OF DIRECTORS view investor presentation Contact Information INVESTOR RELATIONS AND MEDIA Dana Lynch Director, Corporate Communications dlynch@auriniapharma.com IR@auriniapharma.com TRANSFER AGENT Computershare Trust Company of Canada Shareholder Services Dept. 100 University Avenue 9th Floor Toronto, ON M5J 2Y1 Canada T: +1-514-982-7555 service@computershare.com https://www.computershare.com © 2021 Aurinia Pharmaceuticals Inc. All Rights Reserved. Privacy Statement Terms of Use Disclaimer Aurinia Compliance Program Sitemap Update Consent